The Prognostic Value of Tumor Markers in Patients with Glioblastoma Multiforme: Analysis of 32 Patients and Review of the Literature
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 55 (3) , 195-204
- https://doi.org/10.1023/a:1013845004294
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?Anti-Cancer Drugs, 1999
- The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progressionBreast Cancer Research and Treatment, 1995
- Glutathione S-transferases and cytochrome P450 detoxifying enzyme distribution in human cerebral gliomaJournal of Neuro-Oncology, 1995
- Prognostic Significance of p53 Immunoreactivity in Adult Patients with Supratentorial Fibrillary Astrocytic NeoplasmsDiagnostic Molecular Pathology, 1994
- p53 immunohistochemical positivity as a prognostic marker in intracranial tumoursAPMIS, 1994
- Prognostic Significance of Ki-67 Proliferation Index in Supratentorial Fibrillary Astrocytic NeoplasmsNeurosurgery, 1994
- Multidrug resistance gene (MDR 1) expression in neuro-axial tumours of children and young adultsBritish Journal Of Neurosurgery, 1994
- Clinical evaluation of DNA index in human brain tumorsJournal of Neuro-Oncology, 1993
- Brain TumorsNew England Journal of Medicine, 1991
- The proliferation rate of intracranial tumors as defined by the monoclonal antibody KI 67. Application of the method to paraffin embedded specimensNeurosurgical Review, 1988